Notes in Soft tissue sarcoma

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 1.1 \| Introduction
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 1.2 \| Epidemiology
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 1.3 \| Aetiology / risk factors
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 1.4 \| Pathologic classification
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 1.5 \| Histologic grade
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 1.6 \| Immunohistochemistry
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 1.7 \| Molecular diagnostic techniques
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 1.8 \| Frequency of subtypes, anatomical locations and anatomical distribution of subtypes
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 1.9 \| Biologic behaviour
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 2.1 \| Staging
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 2.2 \| Outcomes
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 2.3.1 \| Clinical presentation
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 2.4 \| Workup
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 2.5 \| Prognostic factors
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 3.1 \| Undifferentiated pleomorphic sarcoma (UPS) (formerly Malignant Fibrous Histiocytoma) (20%)
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 3.2 \| Liposarcoma (20%)
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 3.3 \| Fibrosarcoma (10%)
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 3.4 \| Leiomyosarcoma (10%)
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 3.5 \| Rhabdomyosarcoma (5%)
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 3.6 \| Synovial sarcoma (5%)
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 3.7 \| Malignant peripheral nerve sheath tumour (MPNST) (5%)
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 3.8 \| Solitary fibrous tumour (formerly haemangiopericytoma)
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 3.9 \| Angiosarcoma
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 4.1 \| Clear cell sarcoma
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 4.2 \| Gastrointestinal stromal tumours (GIST)
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 4.3 \| Desmoid tumour (aggressive or deep fibromatosis)
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 4.5 \| Ewings/PNET soft tissue sarcoma (extraosseous Ewings)
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 4.6 \| Alveolar soft part sarcoma
Published	02/18/2024	MSK \| Soft tissue sarcoma \| 5.1 \| Management overview
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 5.2.1 \| Extremity STS \| Surgery
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 5.2.2 \| Extremity STS \| Adjuvant RT
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 5.2.3 \| Extremity STS \| Neoadjuvant RT
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 5.2.4 \| Extremity STS \| Definitive RT
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 5.2.6 \| Unplanned or unexpected sarcoma
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 5.2.5 \| Chemotherapy
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 5.3.1 \| Retroperitoneal STS \| Overview
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 5.3.2 \| Retroperitoneal STS \| Radiotherapy
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 5.3.3 \| Retroperitoneal STS \| Chemotherapy
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 6 \| Metastatic disease
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 7 \| RT technique
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 7 \| RT technique - retroperitoneal sarcoma
Published	02/18/2024	MSK \| Soft tissue sarcoma \| 2.3.2 \| Recognising patients for early referral to sarcoma unit
Published	02/18/2024	MSK \| Soft Tissue Sarcoma \| 5.3.2 \| Retroperitoneal STS \| Adjuvant RT \| De-escalation
Status	Last Update	Fields